Europe Takes Leap Of Faith On AstraZeneca Vaccine
EU Confirms Approval, Excuses Lack Of Data In Older Groups
Executive Summary
A conditional marketing authorization for AstraZeneca/Oxford's COVID-19 vaccine came just hours after the European Medicines Agency’s CHMP voted unanimously to recommend it on Friday.
You may also be interested in...
Coronavirus Notebook: EU Publishes AstraZeneca Vaccine Contract, Implements Export Authorization Scheme
The AZ vaccine gets the regulatory go-ahead for use in the EU and the European Medicines Agency says an analysis of data on Pfizer/BioNTech’s Comirnaty has shown no new safety concerns.
Hungary Breaks Ranks With EU & Authorizes Use Of AstraZeneca Vaccine
Hungary is going its own way when it comes to coronavirus vaccines, but its decision to allow the emergency use of the Oxford University/AstraZeneca vaccine may be only a symbolic expression of the government’s growing impatience with the EU.
New Evidence For Kisqali Secures Funding In England For Second-Line Use
The decision by health technology assessment body NICE on Novartis’s advanced breast cancer drug, Kisqali, contrasts sharply with its recommendation for another CDK4/6 inhibitor – Lilly’s Verzenios.
Need a specific report? 1000+ reports available
Buy Reports